You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart

Article: The Continuously Evolving Treatment Landscape In Renal Cell Carcinoma Special,

€3.03

SKU: product-article-13547 Category: General

Description
Reviews (0)

Description

The Continuously Evolving Treatment Landscape In Renal Cell Carcinoma Special,

Reviews

There are no reviews yet.

Be the first to review “Article: The Continuously Evolving Treatment Landscape In Renal Cell Carcinoma Special,”

You must be logged in to post a review.

Top

Article: The Continuously Evolving Treatment Landscape In Renal Cell Carcinoma Special,

Description

Reviews

Related products

Article: Highlights in digestive oncology

Article: Calendar of events

Article: Highlights in urologic cancer

Article: Highlights in squamous cell carcinoma of the head and neck